5 Investors to Follow Other Than Warren Buffett
There is no doubt that Warren Buffett is one of…
Sell
35
MED Quote, Financials, Valuation and Earnings
Last price:
$12.93
Seasonality move
:
18.65%
Day range:
$12.91 - $13.20
52-week range:
$11.57 - $27.16
Dividend yield:
0%
P/E ratio:
69.44x
P/S ratio:
0.26x
P/B ratio:
0.67x
Volume:
228.2K
Avg. volume:
228.6K
1-year change:
-48.28%
Market cap:
$141.9M
Revenue:
$602.5M
EPS (TTM):
-$0.65
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Revenue Growth (YoY) | 30.99% | 63.25% | 4.75% | -32.94% | -43.8% | |
| Cost of Revenues | $237M | $398.5M | $458.2M | $296.2M | $157.8M | |
| Gross Profit | $697.8M | $1.1B | $1.1B | $775.9M | $444.6M | |
| Gross Profit Margin | 74.65% | 73.89% | 71.34% | 72.37% | 73.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Other Inc / (Exp) | -$140K | $119K | -$46K | -$95K | -$3.9M | |
| Operating Expenses | $563.7M | $911.4M | $955.6M | $649.4M | $441.7M | |
| Operating Income | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Net Interest Expenses | -- | $231K | $701K | -- | -- | |
| EBT. Incl. Unusual Items | $134.3M | $216.1M | $184.1M | $128.8M | $3.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.4M | $52.1M | $40.5M | $29.4M | $1.7M | |
| Net Income to Company | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Basic EPS (Cont. Ops) | $8.74 | $14.01 | $12.82 | $9.13 | $0.19 | |
| Diluted EPS (Cont. Ops) | $8.68 | $13.89 | $12.73 | $9.10 | $0.19 | |
| Weighted Average Basic Share | $11.8M | $11.7M | $11.2M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.8M | $11.3M | $10.9M | $11M | |
| EBITDA | $138.5M | $223.1M | $195.7M | $139.5M | $15.6M | |
| EBIT | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Revenue (Reported) | $934.8M | $1.5B | $1.6B | $1.1B | $602.5M | |
| Operating Income (Reported) | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Operating Income (Adjusted) | $134.2M | $216.2M | $184.8M | $126.4M | $2.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $340.7M | $417.6M | $349M | $174.7M | $115.7M | |
| Revenue Growth (YoY) | 90.89% | 22.58% | -16.43% | -49.93% | -33.77% | |
| Cost of Revenues | $92.1M | $115.3M | $102.6M | $47.4M | $31.5M | |
| Gross Profit | $248.5M | $302.3M | $246.4M | $127.3M | $84.2M | |
| Gross Profit Margin | 72.96% | 72.39% | 70.6% | 72.85% | 72.8% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $195.7M | $247.2M | $192.9M | $119.4M | $85.5M | |
| Other Inc / (Exp) | $19K | -$16K | -$1K | $2.4M | $487K | |
| Operating Expenses | $195.7M | $247.2M | $192.9M | $119.4M | $85.5M | |
| Operating Income | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Net Interest Expenses | -- | $95K | $181K | -- | -- | |
| EBT. Incl. Unusual Items | $52.8M | $55M | $53.3M | $11.6M | $526K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.8M | $13.2M | $13.4M | $3.3M | $1.3M | |
| Net Income to Company | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Basic EPS (Cont. Ops) | $3.49 | $3.62 | $3.68 | $0.76 | -$0.07 | |
| Diluted EPS (Cont. Ops) | $3.46 | $3.59 | $3.67 | $0.76 | -$0.07 | |
| Weighted Average Basic Share | $11.8M | $11.6M | $10.9M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.6M | $10.9M | $11M | $10.9M | |
| EBITDA | $53.9M | $57.5M | $56.5M | $11.2M | $2M | |
| EBIT | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Revenue (Reported) | $340.7M | $417.6M | $349M | $174.7M | $115.7M | |
| Operating Income (Reported) | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Operating Income (Adjusted) | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.6B | $1.5B | $897.8M | $543.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $285.9M | $421.7M | $445.4M | $241.1M | $141.9M | |
| Gross Profit | $811.1M | $1.2B | $1.1B | $656.8M | $401.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $647.7M | $962.8M | $901.3M | $575.9M | $407.9M | |
| Other Inc / (Exp) | -$102K | $84K | -$31K | $2.3M | -$5.8M | |
| Operating Expenses | $647.7M | $962.8M | $901.3M | $575.9M | $407.9M | |
| Operating Income | $163.4M | $218.5M | $183.2M | $80.8M | -$6.3M | |
| Net Interest Expenses | -- | $349K | $788K | -- | -- | |
| EBT. Incl. Unusual Items | $163.5M | $218.3M | $182.4M | $87.1M | -$7.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38M | $53.5M | $40.7M | $19.3M | -$275K | |
| Net Income to Company | $125.4M | $164.7M | $141.8M | $67.8M | -$7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $125.4M | $164.7M | $141.8M | $67.8M | -$7M | |
| Basic EPS (Cont. Ops) | $10.66 | $14.15 | $12.87 | $6.16 | -$0.65 | |
| Diluted EPS (Cont. Ops) | $10.59 | $14.02 | $12.79 | $6.15 | -$0.65 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $168.1M | $226.6M | $194.7M | $94.2M | $6.4M | |
| EBIT | $163.4M | $218.5M | $183.2M | $80.8M | -$6.3M | |
| Revenue (Reported) | $1.1B | $1.6B | $1.5B | $897.8M | $543.5M | |
| Operating Income (Reported) | $163.4M | $218.5M | $183.2M | $80.8M | -$6.3M | |
| Operating Income (Adjusted) | $163.4M | $218.5M | $183.2M | $80.8M | -$6.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $340.7M | $417.6M | $349M | $174.7M | $115.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $92.1M | $115.3M | $102.6M | $47.4M | $31.5M | |
| Gross Profit | $248.5M | $302.3M | $246.4M | $127.3M | $84.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $195.7M | $247.2M | $192.9M | $119.4M | $85.5M | |
| Other Inc / (Exp) | $19K | -$16K | -$1K | $2.4M | $487K | |
| Operating Expenses | $195.7M | $247.2M | $192.9M | $119.4M | $85.5M | |
| Operating Income | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Net Interest Expenses | -- | $95K | $181K | -- | -- | |
| EBT. Incl. Unusual Items | $52.8M | $55M | $53.3M | $11.6M | $526K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11.8M | $13.2M | $13.4M | $3.3M | $1.3M | |
| Net Income to Company | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Basic EPS (Cont. Ops) | $3.49 | $3.62 | $3.68 | $0.76 | -$0.07 | |
| Diluted EPS (Cont. Ops) | $3.46 | $3.59 | $3.67 | $0.76 | -$0.07 | |
| Weighted Average Basic Share | $11.8M | $11.6M | $10.9M | $10.9M | $10.9M | |
| Weighted Average Diluted Share | $11.9M | $11.6M | $10.9M | $11M | $10.9M | |
| EBITDA | $53.9M | $57.5M | $56.5M | $11.2M | $2M | |
| EBIT | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Revenue (Reported) | $340.7M | $417.6M | $349M | $174.7M | $115.7M | |
| Operating Income (Reported) | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Operating Income (Adjusted) | $52.8M | $55.1M | $53.5M | $7.9M | -$1.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Short Term Investments | $10.8M | $5.4M | -- | $55.6M | $71.4M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | $53.4M | $180M | $118.9M | $54.6M | $42.4M | |
| Prepaid Expenses | $6.4M | $945K | -- | $19.4M | $9.6M | |
| Other Current Assets | -- | $16.3M | $16.2M | $10.7M | -- | |
| Total Current Assets | $234.3M | $306.9M | $222.8M | $224M | $214.4M | |
| Property Plant And Equipment | $38.1M | $80.6M | $75.6M | $67.1M | $48.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $2.9M | $6.5M | $12.5M | $14.7M | $9.7M | |
| Total Assets | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Accounts Payable | $36.1M | $70.9M | $53.1M | $39.2M | $23.1M | |
| Accrued Expenses | $24.6M | $35.9M | $23.8M | $22.1M | $14M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $6.5M | $5.8M | $5.9M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $111.4M | $169.8M | $140.9M | $92.3M | $64.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $118.8M | $195.9M | $161.2M | $108.4M | $74.1M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $41K | $111K | $24K | $248K | $180K | |
| Common Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $157.2M | $202.5M | $155M | $201.5M | $210.1M | |
| Total Liabilities and Equity | $276.1M | $398.3M | $316.2M | $309.9M | $284.2M | |
| Cash and Short Terms | $174.5M | $109.5M | $87.7M | $150M | $162.3M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $206M | $118M | $123.7M | $97.5M | $91.7M | |
| Short Term Investments | $6.9M | $4.1M | -- | $59M | $72.9M | |
| Accounts Receivable, Net | $88K | -- | -- | -- | -- | |
| Inventory | $62.2M | $189M | $96.9M | $46.3M | $39.4M | |
| Prepaid Expenses | $6.6M | $13.2M | -- | $5.5M | -- | |
| Other Current Assets | -- | -- | $9.7M | $11.4M | $9.6M | |
| Total Current Assets | $281.9M | $324.3M | $230.3M | $219.6M | $213.5M | |
| Property Plant And Equipment | $40.7M | $80.7M | $73.1M | $65.5M | $46.3M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $3.1M | $12M | $13.7M | $13.6M | $8.7M | |
| Total Assets | $326.4M | $421.4M | $321.6M | $302.8M | $280M | |
| Accounts Payable | -- | -- | $113.3M | -- | $51.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $3.7M | $6.7M | $5.4M | $6M | $6.2M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $144.9M | $181M | $131.7M | $77.2M | $60.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $151.5M | $205.4M | $150.7M | $91.8M | $69.1M | |
| Common Stock | $12K | $12K | $11K | $11K | $11K | |
| Other Common Equity Adj | $103K | $127K | $33K | $22K | $239K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $174.9M | $216M | $170.9M | $211M | $211M | |
| Total Liabilities and Equity | $326.4M | $421.4M | $321.6M | $302.8M | $280M | |
| Cash and Short Terms | $212.9M | $122.1M | $123.7M | $156.4M | $164.6M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102.9M | $164M | $143.6M | $99.4M | $2.1M | |
| Depreciation & Amoritzation | $4.3M | $6.8M | $11M | $13.1M | $12.7M | |
| Stock-Based Compensation | $6.8M | $9.9M | $11.1M | $8.2M | $7.4M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$4.6M | -$126.7M | $61.2M | $64.3M | $12.2M | |
| Cash From Operations | $145.2M | $94.5M | $194.6M | $147.7M | $24.5M | |
| Capital Expenditures | $5.9M | $34.2M | $16.7M | $6.5M | $7.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$29.1M | -$11.4M | -$61M | -$26.5M | |
| Dividends Paid (Ex Special Dividend) | -$53.2M | -$63.9M | -$71.6M | -$73M | -$715K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$5.6M | -$62.1M | -$128M | -$7M | -$836K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$57.1M | -$125.1M | -$199.6M | -$79.8M | -$1.5M | |
| Beginning Cash (CF) | $77M | $163.7M | $104.2M | $87.7M | $94.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $86.8M | -$59.7M | -$16.4M | $6.8M | -$3.6M | |
| Ending Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Levered Free Cash Flow | $139.3M | $60.3M | $177.9M | $141.2M | $17M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Depreciation & Amoritzation | $1.1M | $2.4M | $3M | $3.3M | $3.3M | |
| Stock-Based Compensation | $2.2M | $2.3M | $606K | $2.2M | $1.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$8.8M | -$8.9M | $22M | $8.3M | $3.1M | |
| Cash From Operations | $65.3M | $43.7M | $64.1M | $7.3M | $3.4M | |
| Capital Expenditures | $4.6M | $3M | $2.1M | $1.8M | $1.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$878K | -$1.8M | -$2.1M | -$2.8M | -$2.1M | |
| Dividends Paid (Ex Special Dividend) | -$13.4M | -$16.7M | -$19.2M | -$710K | -$194K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$9.3M | -$11.5M | -$6.8M | -$817K | -$369K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$22.2M | -$28.1M | -$25.9M | -$1.5M | -$563K | |
| Beginning Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Foreign Exchange Rate Adjustment | $78K | $30K | $9K | $15K | -- | |
| Additions / Reductions | $42.2M | $13.8M | $36M | $3M | $789K | |
| Ending Cash (CF) | $206M | $118M | $123.7M | $97.5M | $91.7M | |
| Levered Free Cash Flow | $60.7M | $40.7M | $61.9M | $5.4M | $1.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $125.4M | $164.7M | $141.8M | $67.8M | -$7M | |
| Depreciation & Amoritzation | $3.8M | $8.1M | $11.5M | $13.4M | $12.7M | |
| Stock-Based Compensation | $8M | $10M | $9.4M | $9.8M | $7.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$14.4M | -$126.7M | $92.1M | $50.6M | $6.9M | |
| Cash From Operations | $183.8M | $72.9M | $215M | $90.9M | $20.6M | |
| Capital Expenditures | $10.2M | $32.6M | $15.8M | $6.2M | $7.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.9M | -$30M | -$11.8M | -$61.7M | -$25.8M | |
| Dividends Paid (Ex Special Dividend) | -$53.3M | -$67.1M | -$74.1M | -$54.6M | -$199K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$14.4M | -$64.2M | -$123.3M | -$939K | -$388K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$65.6M | -$131M | -$197.4M | -$55.4M | -$587K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $115.3M | -$88.1M | $5.8M | -$26.2M | -$5.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $173.6M | $40.3M | $199.2M | $84.7M | $13.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.1M | $41.8M | $40M | $8.3M | -$772K | |
| Depreciation & Amoritzation | $1.1M | $2.4M | $3M | $3.3M | $3.3M | |
| Stock-Based Compensation | $2.2M | $2.3M | $606K | $2.2M | $1.9M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -$8.8M | -$8.9M | $22M | $8.3M | $3.1M | |
| Cash From Operations | $65.3M | $43.7M | $64.1M | $7.3M | $3.4M | |
| Capital Expenditures | $4.6M | $3M | $2.1M | $1.8M | $1.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$878K | -$1.8M | -$2.1M | -$2.8M | -$2.1M | |
| Dividends Paid (Ex Special Dividend) | -$13.4M | -$16.7M | -$19.2M | -$710K | -$194K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$9.3M | -$11.5M | -$6.8M | -$817K | -$369K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$22.2M | -$28.1M | -$25.9M | -$1.5M | -$563K | |
| Beginning Cash (CF) | $163.7M | $104.2M | $87.7M | $94.4M | $90.9M | |
| Foreign Exchange Rate Adjustment | $78K | $30K | $9K | $15K | -- | |
| Additions / Reductions | $42.2M | $13.8M | $36M | $3M | $789K | |
| Ending Cash (CF) | $206M | $118M | $123.7M | $97.5M | $91.7M | |
| Levered Free Cash Flow | $60.7M | $40.7M | $61.9M | $5.4M | $1.9M | |
Get MED Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MED
Sector
P/E ratio
69.44x
18.28x
PEG ratio
--
0.25x
P/B ratio
0.67x
1.59x
Price / LTM sales
0.26x
0.59x
Growth Metrics
MED
Sector
Revenue growth
-33.77%
1.22%
Earnings growth
-86%
4.05%
Revenue (5-year growth)
-3.33%
4.07%
Earnings forecast
-$0.25
$0.32
Profitability
MED
Sector
Profitability FY 2024
$444.6M
$523.1M
Return on invested capital
-3.35%
5.55%
Return on assets
-2.41%
3.58%
Return on equity
-3.35%
8.35%
Earnings Date
Last Earnings Date
Apr
28
Next Earnings Date
Aug
5
Estimated Next Earnings Date
Jul
28
Balance Sheet
MED
Sector
Total cash
$164.6M
$144.8M
Short term investments
$71.4M
$39.5M
Total assets
$284.2M
$1.8B
Long term debt
--
$213.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
99
DAVE alert for May 9
Dave [DAVE] is up 41.65% over the past day.
Buy
62
RGC alert for May 9
Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.
Buy
85
TPB alert for May 9
Turning Point Brands [TPB] is down 6.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
